5-HT Receptor Agonist Valerenic Acid Enhances the Innate Immunity Signal and Suppresses Glioblastoma Cell Growth and Invasion

Overview

Journal Int J Biol Sci

Specialty Biology

Date 2020 Jun 19

PMID 32549758

Citations 14

Authors

Yuan Ding

Yang Li

Qingli Lu

Affiliations

Soon will be listed here.

Abstract

Glioblastoma multiform (GBM) continues to threaten people's lives due to the limited therapeutic strategies. As a new drug, Valerenic Acid suppresses the progression of GBM, however, the mechanism is largely unknown. Here, we found that Valerenic Acid can inhibit cell proliferation, migration and invasion of GBM cells by increasing innate immune signals such as enhancing ROS levels and activating the AMPK pathway. Inhibition of ROS by N-acetylcysteine (NAC) or attenuation of AMPK by Compound C could block Valerenic Acid-induced cell death. Additionally, the xenograft mouse model also confirmed that Valerenic Acid had anti-tumor effect. Together, our results provide compelling rational to develop Valerenic Acid as an anti-tumor agent against GBM patients.

Citing Articles

Long-Chain Cyclic Arylguanidines as Multifunctional Serotonin Receptor Ligands with Antiproliferative Activity.

Zareba P, Drabczyk A, Wnorowski A, Maj M, Rurka P, Malarz K ACS Omega. 2025; 10(7):6446-6469.

PMID: 40028084 PMC: 11866022. DOI: 10.1021/acsomega.4c06456.

Altered methylation of imprinted genes in neuroblastoma: implications for prognostic refinement.

Suman M, Lofgren M, Fransson S, Yousuf J, Svensson J, Djos A J Transl Med. 2024; 22(1):808.

PMID: 39217334 PMC: 11366169. DOI: 10.1186/s12967-024-05634-5.

Navigating glioblastoma complexity: the interplay of neurotransmitters and chromatin.

Romero-Reyes J, Vazquez-Martinez E, Silva C, Molina-Hernandez A, Diaz N, Camacho-Arroyo I Mol Biol Rep. 2024; 51(1):912.

PMID: 39153092 PMC: 11330389. DOI: 10.1007/s11033-024-09853-3.

PPAR-γ agonists reactivate the ALDOC-NR2F1 axis to enhance sensitivity to temozolomide and suppress glioblastoma progression.

Chang Y, Chan M, Li C, Chen C, Tsai W, Hsiao M Cell Commun Signal. 2024; 22(1):266.

PMID: 38741139 PMC: 11089732. DOI: 10.1186/s12964-024-01645-3.

Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives.

Lin H, Liu C, Hu A, Zhang D, Yang H, Mao Y J Hematol Oncol. 2024; 17(1):31.

PMID: 38720342 PMC: 11077829. DOI: 10.1186/s13045-024-01544-7.

References

Thakkar J, Dolecek T, Horbinski C, Ostrom Q, Lightner D, Barnholtz-Sloan J . Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev. 2014; 23(10):1985-96. PMC: 4185005. DOI: 10.1158/1055-9965.EPI-14-0275. View

Soll C, Riener M, Oberkofler C, Hellerbrand C, Wild P, DeOliveira M . Expression of serotonin receptors in human hepatocellular cancer. Clin Cancer Res. 2012; 18(21):5902-10. DOI: 10.1158/1078-0432.CCR-11-1813. View

Stupp R, Hegi M, Mason W, van den Bent M, Taphoorn M, Janzer R . Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009; 10(5):459-66. DOI: 10.1016/S1470-2045(09)70025-7. View

Dietz B, Mahady G, Pauli G, Farnsworth N . Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Brain Res Mol Brain Res. 2005; 138(2):191-7. PMC: 5805132. DOI: 10.1016/j.molbrainres.2005.04.009. View

Dizeyi N, Bjartell A, Hedlund P, Tasken K, Gadaleanu V, Abrahamsson P . Expression of serotonin receptors 2B and 4 in human prostate cancer tissue and effects of their antagonists on prostate cancer cell lines. Eur Urol. 2005; 47(6):895-900. DOI: 10.1016/j.eururo.2005.02.006. View

Lym R, Ostrom Q, Kruchko C, Couce M, Brat D, Louis D . Completeness and concordancy of WHO grade assignment for brain and central nervous system tumors in the United States, 2004-2011. J Neurooncol. 2015; 123(1):43-51. PMC: 4441798. DOI: 10.1007/s11060-015-1775-4. View

Michaelsen S, Christensen I, Grunnet K, Stockhausen M, Broholm H, Kosteljanetz M . Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution. BMC Cancer. 2013; 13:402. PMC: 3766209. DOI: 10.1186/1471-2407-13-402. View

Egbewande F, Nilsson N, White J, Coster M, Davis R . The design, synthesis, and anti-inflammatory evaluation of a drug-like library based on the natural product valerenic acid. Bioorg Med Chem Lett. 2017; 27(14):3185-3189. DOI: 10.1016/j.bmcl.2017.05.021. View

Simon H, Levi-Schaffer F . Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis. 2001; 5(5):415-8. DOI: 10.1023/a:1009616228304. View

10.

Curtin J, Donovan M, Cotter T . Regulation and measurement of oxidative stress in apoptosis. J Immunol Methods. 2002; 265(1-2):49-72. DOI: 10.1016/s0022-1759(02)00070-4. View

11.

Hejazi S, Ahangari G, Deezagi A . Alternative Viewpoint Against Breast Cancer Based on Selective Serotonin Receptors 5HTR3A and 5HTR2A Antagonists that can Mediate Apoptosis in MCF-7 Cell Line. Curr Drug Discov Technol. 2016; 12(4):240-9. DOI: 10.2174/1570163813666151126215210. View

12.

Chhipa R, Fan Q, Anderson J, Muraleedharan R, Huang Y, Ciraolo G . AMP kinase promotes glioblastoma bioenergetics and tumour growth. Nat Cell Biol. 2018; 20(7):823-835. PMC: 6113057. DOI: 10.1038/s41556-018-0126-z. View

13.

Wilson T, Karajannis M, Harter D . Glioblastoma multiforme: State of the art and future therapeutics. Surg Neurol Int. 2014; 5:64. PMC: 4078454. DOI: 10.4103/2152-7806.132138. View

14.

Siddiqui E, Shabbir M, Mikhailidis D, Thompson C, Mumtaz F . The role of serotonin (5-hydroxytryptamine1A and 1B) receptors in prostate cancer cell proliferation. J Urol. 2006; 176(4 Pt 1):1648-53. DOI: 10.1016/j.juro.2006.06.087. View

15.

Rios M, Foretz M, Viollet B, Prieto A, Fraga M, Costoya J . AMPK activation by oncogenesis is required to maintain cancer cell proliferation in astrocytic tumors. Cancer Res. 2013; 73(8):2628-38. DOI: 10.1158/0008-5472.CAN-12-0861. View

16.

Hejazi S, Ahangari G, Pornour M, Deezagi A, Aminzadeh S, Ahmadkhaniha H . Evaluation of gene expression changes of serotonin receptors, 5-HT3AR and 5-HT2AR as main stress factors in breast cancer patients. Asian Pac J Cancer Prev. 2014; 15(11):4455-8. DOI: 10.7314/apjcp.2014.15.11.4455. View

17.

Stupp R, Mason W, van den Bent M, Weller M, Fisher B, Taphoorn M . Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005; 352(10):987-96. DOI: 10.1056/NEJMoa043330. View

18.

Ohgaki H, Kleihues P . Epidemiology and etiology of gliomas. Acta Neuropathol. 2005; 109(1):93-108. DOI: 10.1007/s00401-005-0991-y. View